Literature DB >> 15585901

Handwriting and attention in children and adults with attention deficit hyperactivity disorder.

Oliver Tucha1, Klaus W Lange.   

Abstract

Adverse effects of drug therapy on handwriting fluency attributed to increased attentional control have been observed in children with attention deficit hyperactivity disorder (ADHD). The writing performance of 8 children with ADHD was assessed using a digitizing tablet in a double-blind, placebo-controlled test. Participants wrote a phrase in cursive script both on and off stimulant medication writing normally, writing with eyes closed, and writing faster than normal. Medication reduced fluency of normal handwriting movements. When children with ADHD were instructed to write faster than normal or with eyes closed, however, more fluent and even automated movements resulted, even on medication. We also assessed 10 children with ADHD, 10 children without ADHD, 10 adults with ADHD, and 10 adults without ADHD. Participants with ADHD were assessed both on and off medication. Children with ADHD on medication were less fluent than children without ADHD. Without medication, Children with ADHD did not differ from children without ADHD; those on medication showed increased handwriting dysfluency. There was no significant difference between the adults. Both children and adults with ADHD could perform age-appropriate and automated handwriting movements. Children with ADHD on medication, however, gave more attention to the writing process, possibly hampering fluent handwriting movements.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15585901     DOI: 10.1123/mcj.8.4.461

Source DB:  PubMed          Journal:  Motor Control        ISSN: 1087-1640            Impact factor:   1.422


  8 in total

1.  Methylphenidate-induced improvements of various measures of attention in adults with attention deficit hyperactivity disorder.

Authors:  O Tucha; L Mecklinger; R Laufkötter; H E Klein; S Walitza; K W Lange
Journal:  J Neural Transm (Vienna)       Date:  2006-08-08       Impact factor: 3.575

2.  Megalographia in children with cerebellar lesions and in children with attention-deficit/hyperactivity disorder.

Authors:  Markus Frings; Kristina Gaertner; Paul Buderath; Hanna Christiansen; Marcus Gerwig; Christoph Hein-Kropp; Beate Schoch; Johannes Hebebrand; Dagmar Timmann
Journal:  Cerebellum       Date:  2010-09       Impact factor: 3.847

3.  Balance Training as an Adjunct to Methylphenidate: A Randomized Controlled Pilot Study of Behavioral Improvement Among Children With ADHD in China.

Authors:  Lei Feng; Yuanchun Ren; Jia Cheng; Yufeng Wang
Journal:  Front Psychiatry       Date:  2021-01-08       Impact factor: 4.157

Review 4.  How effective is fine motor training in children with ADHD? A scoping review.

Authors:  Miriam Lelong; Annina Zysset; Mirjam Nievergelt; Reto Luder; Ulrich Götz; Christina Schulze; Frank Wieber
Journal:  BMC Pediatr       Date:  2021-11-04       Impact factor: 2.125

Review 5.  Motor Functional Characteristics in Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorders: A Systematic Review.

Authors:  Shunsuke Takagi; Hikaru Hori; Tatsuya Yamaguchi; Shinichiro Ochi; Masaki Nishida; Takashi Maruo; Hidehiko Takahashi
Journal:  Neuropsychiatr Dis Treat       Date:  2022-08-09       Impact factor: 2.989

6.  Methylphenidate improves motor functions in children diagnosed with Hyperkinetic Disorder.

Authors:  Liv Larsen Stray; Torstein Stray; Synnøve Iversen; Anne Ruud; Bjørn Ellertsen
Journal:  Behav Brain Funct       Date:  2009-05-13       Impact factor: 3.759

7.  Handwriting in children with Attention Deficient Hyperactive Disorder: role of graphology.

Authors:  Rony Cohen; Batia Cohen-Kroitoru; Ayelet Halevy; Sharon Aharoni; Irena Aizenberg; Avinoam Shuper
Journal:  BMC Pediatr       Date:  2019-12-10       Impact factor: 2.125

8.  Can jaw position affect the fine motor activity of the hand during writing?

Authors:  Ahmad H Alghadir; Hamayun Zafar; Zaheen A Iqbal
Journal:  Brain Behav       Date:  2020-10-21       Impact factor: 2.708

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.